# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Diarrhea

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 118 results.
The Effect of a Multispecies Probiotic on Reducing the Incidence of Antibiotic-associated Diarrhoea in Children.
Status: Recruiting
Last Changed: Mar 01, 2018
First Received: Nov 07, 2017
Disease(s): Antibiotic-associated Diarrhea
Intervention(s): Multispecies probiotic, Placebo
Locations: Department of Paediatrics, The Medical University of Warsaw, Poland, Warsaw, Poland
Yield of Diagnostic Tests and Effects of Crofelemer for Chronic Idiopathic Diarrhea In Non-HIV Patients
Status: Not yet recruiting
Last Changed: Apr 03, 2019
First Received: Apr 02, 2019
Disease(s): Chronic Diarrhea of Unknown Origin
Intervention(s): Crofelemer, Diagnostic tests for cause of chronic diarrhea
Locations: The University of Texas Health Science Center at Houston, Houston, Texas, United States
Effect of Lactobacillus Reuteri DSM 17938 to Prevent Antibiotic-associated Diarrhea in Children
Status: Recruiting
Last Changed: Feb 08, 2019
First Received: May 06, 2016
Disease(s): Antibiotic Associated Diarrhea
Intervention(s): Lactobacillus reuteri DSM 17938, Placebo, Amoxicillin-Clavulanic Acid
Locations: Sisli Etfal Training and Research Hospital,, Istanbul,, Turkey
Mechanisms of Preventing Antibiotic-Associated Diarrhea and the Role for Probiotics
Status: Recruiting
Last Changed: Aug 15, 2019
First Received: Nov 28, 2018
Disease(s): Antibiotic-associated Diarrhea
Intervention(s): Amoxicillin-Clavulanate 875 Mg-125 Mg Oral Tablet, BB-12, Control
Locations: Georgetown University Department of Family Medicine, Washington, District of Columbia, United States
A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea
Status: Recruiting
Last Changed: Apr 04, 2019
First Received: Jan 04, 2019
Disease(s): Clostridium Difficile Diarrhea
Intervention(s): PBCLN-003, Placebo
Locations: Infectious Disease Specialist, Idaho Falls, Idaho, United States
Probiotics in the Prevention of Antibiotic Induced Diarrhea and Clostridium Difficile Associated Diarrhea.
Status: Not yet recruiting
Last Changed: Aug 27, 2018
First Received: Aug 27, 2018
Disease(s): Diarrhea, Clostridium Difficile
Intervention(s): Probiolife by Green Made (Pharma M), Placebo
A Study Evaluating Bacillus Cereus in the Prevention of Afatinib-associated Diarrhea
Status: Recruiting
Last Changed: May 30, 2018
First Received: Apr 03, 2018
Disease(s): Diarrhea, Treatment Side Effects
Intervention(s): Bacillus Cereus tablets
Locations: Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, China
Allogeneic Microbiota-reconstitution (AMR) in Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Sep 19, 2019
Disease(s): Diarrhea-predominant Irritable Bowel Syndrome
Intervention(s): Allogeneic microbiota reconstitution, Placebo-Allogeneic microbiota reconstitution
Locations: Helios Klinikum Krefeld, Krefeld, Germany
Ulm University Hospital, Ulm, Germany
Study to Evaluate the Efficacy, Safety, and Tolerability of BOS-589 in the Treatment of Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS-D)
Status: Recruiting
Last Changed: Jul 04, 2019
First Received: Jun 06, 2019
Disease(s): Diarrhea-predominant Irritable Bowel Syndrome
Intervention(s): BOS-589, Placebo
Locations: Clinical Research Associates, Huntsville, Alabama, United States
Synexus Clinical Research US, Inc. - East Valley Family Physicians, PLC, Chandler, Arizona, United States
Synexus Clinical Research US, Inc. - Phoenix Southeast, Chandler, Arizona, United States
Synexus Clinical Research US, Inc., Glendale, Arizona, United States
Synexus Clinical Research US, Inc. - Desert Clinical Research, LLC, Mesa, Arizona, United States
... and 29 other locations.
Prevention of Irinotecan Induced Diarrhea by Probiotics
Status: Recruiting
Last Changed: Jan 17, 2019
First Received: Jun 30, 2016
Disease(s): Diarrhea, Cancer
Intervention(s): PROBIO-FIX INUM®, Placebo
Locations: National Cancer Institute, Bratislava, Slovakia